Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer.G. R. Hudes, C McAleer, Carine Khater et al.|Journal of Clinical Oncology|1997Cited by 273
Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer.Bruce J. Giantonio, Louis M. Weiner, Bertil Persson et al.|Journal of Clinical Oncology|1997Cited by 82